Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
Transplantation and Cellular Therapy
|
July 4, 2024
CAR-T Therapy for All: Addressing the Access Gap
Marco Ruella
Cancer Cell
|
December 12, 2023
ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma
Marco Ruella
The Lancet. Haematology
|
March 16, 2025
CAR T-cell therapy in LMICs: approval of talicabtagene autoleucel in India
Luca Paruzzo, Marco Ruella
Expert Opinion on Biological Therapy
|
February 3, 2015
How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia
Marco Ruella, Saar Gill
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly
Marco Ruella, Pierre Soubeyran
Immunological Reviews
|
December 17, 2013
Adoptive immunotherapy for cancer
Marco Ruella, Michael Kalos
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 23, 2018
Predicting Dangerous Rides in CAR T Cells: Bridging the Gap between Mice and Humans
Marco Ruella, Carl H June
Annals of Translational Medicine
|
February 9, 2016
Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma
Marco Ruella, Bruce L Levine
Computational and Structural Biotechnology Journal
|
October 21, 2016
Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies
Marco Ruella, Marcela V Maus
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 17, 2017
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Marco Ruella, Saad S Kenderian
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
Transplantation and Cellular Therapy
|
July 4, 2024
CAR-T Therapy for All: Addressing the Access Gap
Marco Ruella
Cancer Cell
|
December 12, 2023
ALKemy to enhance chimeric antigen receptor T cell immunotherapy for neuroblastoma
Marco Ruella
The Lancet. Haematology
|
March 16, 2025
CAR T-cell therapy in LMICs: approval of talicabtagene autoleucel in India
Luca Paruzzo, Marco Ruella
Expert Opinion on Biological Therapy
|
February 3, 2015
How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia
Marco Ruella, Saar Gill
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly
Marco Ruella, Pierre Soubeyran
Immunological Reviews
|
December 17, 2013
Adoptive immunotherapy for cancer
Marco Ruella, Michael Kalos
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 23, 2018
Predicting Dangerous Rides in CAR T Cells: Bridging the Gap between Mice and Humans
Marco Ruella, Carl H June
Annals of Translational Medicine
|
February 9, 2016
Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma
Marco Ruella, Bruce L Levine
Computational and Structural Biotechnology Journal
|
October 21, 2016
Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies
Marco Ruella, Marcela V Maus
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 17, 2017
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Marco Ruella, Saad S Kenderian
Page
of 14